Efficacy and Safety of Morning Versus Evening Intake of Simvast CR Tablet in Patients With Hyperlipidemia: A Randomized, Double-blind, Multicenter Phase 3 Trial.
Phase of Trial: Phase III
Latest Information Update: 17 Oct 2016
At a glance
- Drugs Simvastatin (Primary)
- Indications Hyperlipidaemia
- Focus Therapeutic Use
- Sponsors Hanmi Pharmaceutical
- 10 Jun 2017 Biomarkers information updated
- 29 Aug 2013 Results published in the Clinical Therapeutics.
- 29 Aug 2013 Primary endpoint 'LDL-cholesterol-level' has been met.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History